[The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].
Meier
W
W
Stieber
P
P
Fateh-Moghadam
A
A
Eiermann
W
W
Hepp
H
H
D000951:Antigens, Neoplasm / Q000097:blood*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000188:drug therapy*; D011379:Prognosis; D015843:Serpins; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000188:drug therapy*
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015843:Serpins; C051072:squamous cell carcinoma-related antigen
SCC-Verlauf unter Chemotherapie als Prognosekriterium beim Zervixkarzinom.